AC Immune (ACIU) Cash from Operations (2015 - 2025)
AC Immune (ACIU) posted quarterly Cash from Operations of 20932070.62 for Q4 2025, down 409.02% year-over-year from 6773790.65 in Q4 2024, and up 10.36% quarter-over-quarter from 23352045.73 in Q3 2025.
Powered by 
Analysis
AC Immune (ACIU) Cash from Operations (2015 - 2025) Analysis & Trends
AC Immune (ACIU) has reported Cash from Operations for 11 consecutive years, with 20932070.62 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Operations fell 409.02% year-over-year to 20932070.62; the TTM figure through Dec 2025 stood at 85385299.71 (down 217.97% YoY), while the FY2025 annual figure was 85598939.26, down 213.89% from the prior year.
- Cash from Operations improved to 20932070.62 in Q4 2025 per ACIU's latest filing, from 23352045.73 in the prior quarter.
- Across five years, Cash from Operations topped out at 80752780.98 in Q2 2024 and bottomed at 25059434.29 in Q1 2022.
- Historically, Cash from Operations has averaged 11495192.53 across 5 years, with a median of 18116729.95 in 2022.
- Annual changes were most pronounced in 2024 — Cash from Operations jumped 611.76% — and 2025, when it tumbled 1935.27%.
- AC Immune's Cash from Operations stood at 19334503.4 in 2021, then climbed by 6.55% to 18068847.43 in 2022, then dropped by 2.14% to 18454792.73 in 2023, then jumped by 136.7% to 6773790.65 in 2024, then slumped by 409.02% to 20932070.62 in 2025.
- Business Quant data shows ACIU's Cash from Operations at 20932070.62 in Q4 2025, 23352045.73 in Q3 2025, and 19570237.49 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -20.93 Mn |
| Sep 30, 2025 | -23.35 Mn |
| Jun 30, 2025 | -19.57 Mn |
| Mar 31, 2025 | -21.53 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Sep 30, 2024 | -16.32 Mn |
| Jun 30, 2024 | 80.75 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | -18.45 Mn |
| Sep 30, 2023 | -15.25 Mn |
| Jun 30, 2023 | -15.78 Mn |
| Mar 31, 2023 | -18.16 Mn |
| Dec 31, 2022 | -18.07 Mn |
| Sep 30, 2022 | -14.02 Mn |
| Jun 30, 2022 | -20.23 Mn |
| Mar 31, 2022 | -25.06 Mn |
| Dec 31, 2021 | -19.33 Mn |
| Sep 30, 2021 | -15.79 Mn |
| Jun 30, 2021 | -17.57 Mn |
| Mar 31, 2021 | -19.18 Mn |